The tumour necrosis factor as a mediator of vessel inflammation: importance of exposed receptor residues for its neutralization

References

• Kim YS, Morgan MJ, Choksi S, Liu ZG. TNF-induced activation of the Noxl NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007; 26(5): 675–687.
   PubMed Web of Science ®Google Scholar
• Vielhauer V, Mayadas TN. Functions of TNF and its receptors inrenal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nephrol 2007; 27(3): 286–308.
   PubMed Web of Science ®Google Scholar
• Assi Lk, Wong SH, Ludwig A et al. Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint. Arthritis Rheum 2007; 56(6): 1776–1786.
   PubMed Web of Science ®Google Scholar
• Gabdoulline RR, Wade R, Walther D. MolSurfer: a macromole-cular interface navigator. Nucleid Acids Res 2003; 31(13): 3349–3351.
   PubMed Web of Science ®Google Scholar
• Finn RD, Marshall M, Bateman A. iPfam: visualization of protein-protein interactions in PDB at domain and amino acid resolutions. Bioinformatics 2005; 21(3): 410–412.
   PubMed Web of Science ®Google Scholar
• Mount DW. Bioinformatics: sequence and genome analysis. ColdSpring Harbor/New York: Cold Spring Harbor laboratory Press, 2001.
   Google Scholar
• Lesk AM. Introduction to bioinformatics. Oxford: Oxford University Press, 2002.
   Google Scholar
• Gibas C and Jambeck P. Developing bioinformatics computer skills. Sebastopol, CA: O'Reilly, 2001.
   Google Scholar
• Chang PL. Clinical bioinformatics. Chang Gung Med J2005; 28(4):201–211.
   PubMedGoogle Scholar
• Berman HM, Westbrook J, Feng Z et al. The Protein Data Bank. Nucl Acids Res 2000; 28: 235–242.
   PubMed Web of Science ®Google Scholar
• Banner DW, D'Arcy A, Janes W et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 1993; 73: 431–445.
   PubMed Web of Science ®Google Scholar
• Guex N, Peitsch MC. Swiss-model and the Swiss-Pdb viewer: an environment for comparative protein modelling. Electrophoresis 1997; 18: 2714–2723.
   PubMed Web of Science ®Google Scholar
• Dupuis F, Sadoc JF, Jullien R, Angelov B, Mornon JP. Voro3D: 3D voronoi tessellations applied to protein structures. Bioinformatics 2005; 21(8): 1715–1716.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Wesson M, Yamashita M. Interpretation of protein folding and binding with atomic solvation parameters. Chem Scr 1989; 29A: 217–221.
   Google Scholar
• Schulz GE, Schirmer RH. Principles of protein structure. New York: Springer, 1979.
   Google Scholar
• Wiltgen M, Holzinger A, Tilz GP. Interactive analysis and visualization of macromolecular interfaces between proteins. Lecture notes in computer sciences. Vol. 4799. Berlin/Heidelberg: Springer, 2007; 199–212.
   Google Scholar
• Wiltgen M, Tilz GP. Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts. Hematology 2008; 13(4): 224–229.
   PubMed Web of Science ®Google Scholar
• Voronoi G. Recherche sur les paralleloedres primitifs. J. Reine Angw Math 1908; 134: 198–287.
   Google Scholar
• Dupuis F, Sadoc JF, Mornon JP. Protein secondary structure assignment through voronoi tessellation. Proteins 2004; 55: 519–528.
   PubMed Web of Science ®Google Scholar
• Angelov B, Sadoc JF, Jullien R, Soyer A, Mornon JP, Chomilier J. Nonatomic solvent-driven Voronoi tessellation of proteins: a open tool to analyze protein folds. Proteins 2002; 49: 446–456.
   PubMed Web of Science ®Google Scholar
• Duncan B, Olson AL Approximation and characterization of molecular surfaces. Biopolymers 1993; 33: 219–229.
   PubMed Web of Science ®Google Scholar
• Gabdoulline RR, Wade RC. Analytically defined surfaces to analyze molecular interaction properties. J Mol Graph 1996; 14(6): 341–353,374–375.
   PubMedGoogle Scholar
• Casal ML, Scheidt JL, Rhodes JL, Henthorn PS, Werner P. Mutation identification in a canine model of X-linked ectodermal dysplasia. Mamm. Genome 2005; 16(7): 524–531.
   PubMed Web of Science ®Google Scholar
• Tang ED, Wang CY, Xiong Y, Guan KL. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem 2003; 278(39): 37297–37305.
   PubMed Web of Science ®Google Scholar
• Lentz M, Kumar K. Reduction of plasma levels of soluble tumour necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column. Ther Apher Dial 2008; 12(6): 491–499.
   PubMed Web of Science ®Google Scholar
• Bendtzen K, Ainsworth M, Steenholdt C, Thomsen OO, Brynskov J. Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-soluble tumour necrosis factor alpha antibodies. Scand J Gastroenterol 2009; 13: 1–8.
   Google Scholar
• Rebelo SL, Amel-Kashipaz MR, Radford PM et al. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheum 2009; 60(1): 269–280.
   PubMed Web of Science ®Google Scholar
• Boettger MK, Hensellek S, Richter F et al. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum 2008; 58(8): 2368–2378.
   PubMed Web of Science ®Google Scholar
• Lo J, Bernstein LE, Canavan B et al. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab 2007; 293(1): E102–109.
   PubMed Web of Science ®Google Scholar
• Taoufik E, Tseveleki V, Euagelidou M et al. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis. Neurodegener Dis 2008; 5(1): 32–37.
   PubMed Web of Science ®Google Scholar
• Mihara K, Almansa C, Smeets RL et al. A potent and selective p38inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNF alpha. Br J Pharmacol 2008; 154(1): 153–164.
   PubMed Web of Science ®Google Scholar
• De Wilde G, Murray-Rust J, Boone E et al. Structure-activity relationship of the p55 TNF receptor death domain and its lymphoproliferation mutants. Eur J Biochem 2001; 268(5): 1382–1391.
   PubMedGoogle Scholar
• Barbara JA, Smith WB, Gamble JR et al. Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor-and p75 receptor-selective TNF-alpha mutants. EMBO J 1994; 13(4): 843–850.
   PubMed Web of Science ®Google Scholar
• Jacobsen SE, Jacobsen FW, Fahlman C, Rusten LS. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells 1994; 12(Suppl 1): 111–126.
   PubMedGoogle Scholar
• Kimberley FC, Lobito AA, Siegel RM, Screaton GR. Falling into TRAPS-receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther 2007; 9(4): 217.
   PubMed Web of Science ®Google Scholar
• Tilz GP, Wiltgen M, Demel U, Faschinger C, Schmiedinger H, Hermetter A. Introduction of three complementary technologies into clinical medicine: development of new diagnostic and prognostic parameters. Am J Immun 2006; 2(1): 12–18.
   Google Scholar